BioNTech

The growing inequality between vaccines around the world has affected the poorer countries the most, especially the African countries. In an attempt to bridge the gap, Germany's BioNTech, the developers of the first mRNA vaccines against COVID-19 together with Pfizer, announced plans to send mobile vaccine production units to Africa. "The question was, can we make the process compact enough to fit in a container," BioNTech CEO and co-founder Uğur Şahin told Agence France-Presse (AFP) when the company…

After Johnson & Johnson allied itself with Aspen, it is Pfizer / BioNTech's turn to partner with a South African company to produce its anticovid vaccine. The manufacturer has signed an agreement with the Biovac Institute, a semi-state company based in Cape Town. This will be the first time a Messenger RNA vaccine has been produced in Africa. Target: 100 million doses per year by 2023. Production…